Clinical Laboratory Technology (China) study materials
Clinical Laboratory Technology (China) study resources

Clinical Laboratory Technology (China): Microbiology methods and presumptive identification

Clinical Laboratory Technology (China) · Work through your exam, one topic at a time.

All guide sections

Microbiology methods and presumptive identification

Diagnostic microbiology connects specimen quality, organism recovery or detection and clinical significance. A positive result may represent infection, colonization or contamination depending on the site, collection and patient context. A negative result can reflect timing, prior treatment, sampling or method limitations. The laboratory should document relevant specimen conditions rather than assume culture provides a complete census of organisms present.

Microscopy and stains give early information. Gram-stain behavior depends on organism properties, specimen condition and technique, especially decolorization. Acid-fast staining reflects particular cell-envelope characteristics and is not a complete species identification. Morphology and staining can guide further work while appropriate biosafety precautions remain in place. Never deliberately smell a culture to identify it; descriptive historical odors are not a safe bench procedure.

Culture media can be enriched, selective or differential. These roles are not interchangeable: a medium may inhibit some competitors while displaying a biochemical reaction in those that grow. A colony color or a single enzyme test is usually part of a presumptive identification pattern. Exceptions occur, and validated contemporary identification methods and confirmatory work may be needed before reporting the final organism.

Susceptibility testing requires standardized procedures, suitable quality controls and current organism-drug interpretation criteria. Disk diffusion, inhibitory concentration and bactericidal concentration answer different questions. A resistance mechanism can inform concern, but does not by itself establish one universally effective drug or dosing plan. Testing conditions, breakpoints and reporting algorithms must be checked in the currently applicable framework rather than inferred from a memorized historical table.

Biological risk depends on agent, procedure, concentration and potential exposure. Handling an unopened clinical specimen is not equivalent to propagating a high-consequence organism. Containment and equipment must follow a documented risk assessment and appropriate institutional guidance. A cabinet or respirator label alone does not replace safe technique, training and validated decontamination. This conceptual question bank does not authorize culturing hazardous pathogens or supply a complete operational protocol for clinical microbiology work.